Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0228761 METHODS FOR THE TREATMENT OF MAST CELL RELATED DISORDERS WITH MAST CELL STABILIZERS
Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
2018/0228760 Antimicrobial Compositions Comprising Mupirocin and Neomycin
The present invention features a composition comprising mupirocin and neomycin, a formulation thereof and a method of treating microbial infection using the...
2018/0228759 MONOACYLGLYCEROLS FOR USE IN CONJUNCTION WITH A LIPASE INHIBITOR AND/OR DIETS LOW IN FAT AND/OR CALORIES
In an embodiment, compositions comprising monoacylglycerols (MAG), such as sn-1 MAG, are administered with a lipase inhibitor, such as tetrahydrolipstatin,...
2018/0228758 COMPOSITIONS AND METHODS TO TREAT INFECTED EAR CONDITIONS
Methods of treating Otitis externa by inhibiting the growth of, or killing, certain microorganisms associated with this condition are disclosed. Prophylaxis...
2018/0228757 EDIBLE PARTICLES COMPRISING A POLYSACCHARIDE AND A LIPID
The invention provides ingestible particles comprising an intimate mixture of a water-soluble or water-insoluble polysaccharide component and a fatty acid...
2018/0228756 METHOD OF DIETARY TREATMENT FOR GENETIC AND EPIGENETIC DISEASES AND DISORDERS
Genetic and epigenetic diseases and disorders are treated with FDA approved dietary compositions in the form of dietary supplements and nutraceuticals. The...
2018/0228755 VEGETARIAN COMPOSITION CONTAINING UNSATURATED FATTY ACIDS
Differing from commercial dietary supplements of EPA and DHA are made by using abyssal fishes as primary raw materials, the present invention provides an...
2018/0228754 CO-CRYSTALS OF SUBSTITUTED GLYCINE AND USES THEREOF
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): ##STR00001## compositions comprising such,...
2018/0228753 CO-CRYSTALS OF SUBSTITUTED GLYCINE AND USES THEREOF
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): ##STR00001## compositions comprising such,...
2018/0228752 Treatment of NAFLD and NASH
Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
2018/0228751 USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
The present invention relates to the use of a therapeutically effective amount of cannabidiolic acid (CBDA) in the treatment of epilepsy. In one embodiment the...
2018/0228750 SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS
The present invention concerns the use of compounds for preventing and/or treating osteoporosis, for stimulating bone formation, for stimulating bone...
2018/0228749 SURFACTANTS AND COMPOSITIONS FOR TREATMENT OF VIRAL SKIN CONDITIONS
Disclosed is a surfactant, or a pharmaceutically acceptable salt or a stereoisomer thereof, and a composition including the surfactant, for post infection...
2018/0228748 INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS
Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically...
2018/0228747 RECTAL TOPICAL LIPOGEL COMPRISING AN ANESTHETIC AGENT AND A NON-STEROIDAL ANTI-INFLAMMATORY AGENT FOR PAIN RELIEF
It relates to a topical gel composition comprising lidocaine or its pharmaceutically acceptable salts and diclofenac or its pharmaceutically acceptable salts,...
2018/0228746 Medications For Deposition On Biological Surfaces
Personal care compositions, such as oral medication compositions containing a flavor system comprising one or more coolants. The pleasant cool sensation...
2018/0228745 SUBSTANCE SELECTED AMONG MIDODRINE, A PHARMACEUTICAL SALT AND AN ACTIVE METABOLITE THEREOF, FOR USE IN THE...
Some embodiments are directed to a substance for use in the treatment of obstructive cardiopathy, and in particular to a substance selected among midodrine, a...
2018/0228744 ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS
The present invention involves the use of 2,4-disulfonyl phenyl tert-butyl nitrone (2,4-ds-PBN) in the treatment and prevention of gliomas. The 2,4-ds-PBN may...
2018/0228743 COMPOUNDS AND METHODS OF PROMOTING MYELINATION
A method of promoting the generation of oligodendrocytes from oligodendrocyte precursor cells by enhancing their survival and/or maturation includes...
2018/0228742 Compositions for use in the treatment of diabetes
This invention relates to compositions for use in the treatment of diabetes, for example type-2 diabetes; obesity; and/or metabolic syndrome. Specifically, the...
2018/0228741 REDUCTION OF ADIPOSE TISSUE
Described herein, inter alia, are compositions, formulations, methods, and systems for reducing regional fat deposits and treating fat-related conditions.
2018/0228740 COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY
Pharmaceutical compositions for the treatment of cancer are provided. In one embodiment the composition comprises Gamitrinib and a MAPK inhibitor selected from...
2018/0228739 Dermal Delivery Device
A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of...
2018/0228738 DEVICE AND METHOD OF TREATING CONDITIONS ASSOCIATED WITH NEUROINFLAMMATION
Disclosed is a device and method for treating a neurodegenerative disease or condition associated with neuroinflammation induced by a leukotriene. The device...
2018/0228737 METHODS AND SYSTEMS FOR DEPOSITING ACTIVE INGREDIENTS ON SUBSTRATES
Systems and methods for delivering active ingredients, such as pharmaceutically active ingredients, to substrates are described herein. The active ingredients...
2018/0228736 NANO-ENCAPSULATION USING GRAS MATERIALS AND APPLICATIONS THEREOF
In one aspect, methods of preparing composite nanoparticle compositions are described herein. For example, in some embodiments, a method comprises providing a...
2018/0228735 MESOPOROUS CALCIUM PHOSPHATE-CITRATE NANOPARTICLES AND USES THEREOF
The present invention relates to mesoporous calcium phosphate-citrate nanoparticles, optionally comprising a lipid membrane, and pharmaceutical compositions...
2018/0228734 COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION
The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful...
2018/0228733 MEDICAMENT-CONTAINING HOLLOW PARTICLE
The invention provides a particle composed of a shell and a hollow, wherein the shell contains a medicament and a polymer, and a volume ratio of the hollow...
2018/0228732 SUSTAINED-RELEASE FORMULATION
The present invention relates to a sustained-release formulation comprising a metastin derivative and a lactic acid-glycolic acid copolymer having a weight...
2018/0228731 POLYPHENOLIC POLYMER TO MAKE WATER-INSOLUBLE MOLECULES BECOME WATER-SOLUBLE
The subject invention relates to compositions of a polyphenolic Polymer and methods useful for the delivery of substantially water-insoluble drugs and...
2018/0228730 USE OF WATER-SOLUBLE POLYMERS BASED ON N-VINYLPYRROLIDONE AND ACRYLIC ACID AS PHARMACEUTICAL ADJUVANTS
Use of a water-soluble polymer having a solubility in water of greater than 5% (m/m) in the pH range of 1 to 13 and which is obtained by free-radically...
2018/0228729 METHOD FOR PREPARING OPHTHALMIC PREPARATION CONTAINING THYMOSIN BETA-4
The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin .beta.4. According to the inventive method, the...
2018/0228728 DOSAGE FORM FOR ADMINISTRATION OF OPIOID ANTAGONISTS
A novel dosage form for delivering an opioid antagonist such as naloxone is disclosed. The dosage form comprises an oral dissolvable film containing an amount...
2018/0228727 TASTE-MASKED PHARMACEUTICAL COMPOSITIONS
There is provided a method for preparing an orally disintegrating tablet (ODT) composition comprising microparticles of one or more taste-masked active...
2018/0228726 THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG...
Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many...
2018/0228725 DRUG DELIVERY DEVICES FOR DELIVERY OF OCULAR THERAPEUTIC AGENTS
Drug delivery devices comprising a non-bioabsorbable polymer structure configured to support a composition comprising an active agent. The devices include a...
2018/0228724 DRIPPABLE OPHTHALMIC BIMATOPROST GEL
The invention refers to a drippable ophthalmic gel, said gel having composition comprising bimatoprost in an amount of 0.003 to 0.03% by weight, polyacrylate...
2018/0228723 OIL-IN-WATER EMULSION OF MOMETASONE
Novel pharmaceutical compositions of mometasone or a pharmaceutically acceptable derivate thereof in the form of an oil-in-water emulsion, notably a cream. The...
2018/0228722 UNIT DOSE PACKAGES, COMPOSITIONS, AND TREATMENT REGIMENS TO DELIVER PRO-RESOLUTION PATHWAY STIMULATORS TO...
A method for making a unit dose package containing a Pro-Resolution Pathway Stimulator that may be an Inflammatory Metabolite Inhibitor or a Pro-Resolving...
2018/0228721 Functional and capable cosmetic compositions, that are appeasing to the senses, particularly visual and psyche,...
A functional and capable cosmetic composition, that is appeasing to the senses, particularly visual and psyche, useful for social interaction, and topical skin...
2018/0228720 MELANOGENESIS INHIBITOR
The present invention addresses the problem of providing a novel melanogenesis inhibitor capable of safely inhibiting melanism caused by ultraviolet radiation...
2018/0228719 OXIDATION DYEING AGENT WITH SPECIAL HYDROXY-TERMINATED, AMINE-FUNCTIONALIZED SILICONE POLYMERS
The present disclosure relates to a cosmetic agent for dyeing keratinous fibers, more particularly human hair, containing at least one special ...
2018/0228718 COSMETIC COMPOSITION COMPRISING A CATIONIC SURFACTANT, A FATTY ALCOHOL AND TWO NONIONIC POLYMERS
Cosmetic composition comprising a cationic surfactant, a fatty alcohol and two nonionic polymers The invention relates to a composition for the cosmetic...
2018/0228717 COSMETIC
A cosmetic is disclosed, which provides easy-to-spread lightness at the start of application, in the course of application, and at the end of application,...
2018/0228716 Essence of alayah - hair seen
The Essence Of Alayah--Hair Seen (EOA), is a hair sheen or hair polish that is specially designed and formulated to add a brilliant sheen, gloss, or shine to...
2018/0228714 STABLE VITAMIN C COMPOSITIONS
Disclosed is a composition comprising ascorbic acid or a derivative thereof, a silicone containing compound, and an essential oil, wherein at least 50% of the...
2018/0228713 HAIR SHAPING COMPOSITION
The invention provides a hair shaping composition suitable for topical application to hair, the composition having a pH of 4 or less and comprising, in an...
2018/0228712 Oral Care Product and Methods of Use and Manufacture Thereof
Described herein, are compositions comprising an effective amount of a basic amino acid in free or salt form, and a water soluble strontium salt; and methods...
2018/0228711 3-(4-HYDROXYPHENYL) PROPANOIC ACID AMIDE FOR USE IN TISSUE REPAIR AND/OR SKIN BRIGHTENING
In one aspect the present invention relates to 3-(4-hydroxyphenyl)propanoic acid amide (PA) for use as a tissue repair agent. In a second aspect, the present...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.